Related Experiment Video
Updated: May 17, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Regional HTA in Italy: promising or confusing?
Livio Garattini1, Katelijne van de Vooren, Alessandro Curto
1CESAV, Center for Health Economics, 'Mario Negri' Institute for Pharmacological Research, Via Camozzi 3, 24020 Ranica, Italy. lgarattini@marionegri.it
Health Policy (Amsterdam, Netherlands)
|November 13, 2012
Summary
Regional health technology assessment (HTA) implementation in Italy shows significant disparities. While many regions have established HTA workgroups, formal funding and comprehensive report content remain limited, particularly regarding ethical and legal considerations.
Area of Science:
- Health Services Research
- Health Technology Assessment
- Public Health Policy
Background:
- Regional health technology assessment (HTA) plays a crucial role in evidence-based healthcare decision-making.
- The implementation and effectiveness of regional HTA initiatives can vary significantly due to diverse healthcare landscapes.
- Assessing the current state of regional HTA in Italy is essential for identifying strengths and areas for improvement.
Purpose of the Study:
- To evaluate the actual implementation and achievements of regional HTA across Italy.
- To identify key elements of HTA structure and process within Italian regions.
- To analyze the content and scope of published regional HTA reports.
Main Methods:
- A web-based analysis was conducted, examining data up to July 2012.
- Six key HTA implementation elements were assessed: document availability, workgroup existence, external involvement, funding, report publication, and network membership.
- Content analysis of retrieved HTA reports focused on clinical efficacy, economic evaluation, legal, ethical, and organizational aspects.
Main Results:
- Sixteen Italian regions have established formal HTA workgroups.
- Specific funding for HTA was identified in only six regions, with web-available reports in just four.
- Approximately 91% of reports focused on pharmaceuticals, primarily covering epidemiological and clinical data, with limited economic, organizational, ethical, legal, or social issue analysis.
Conclusions:
- The implementation of regional HTA in Italy presents a highly uneven landscape.
- Significant variations exist among regions in their capacity to conduct HTA, likely influenced by differences in size, healthcare tradition, and expertise.
- There is a need to enhance the comprehensiveness of regional HTA reports to include broader ethical, legal, social, and organizational dimensions alongside clinical and economic evaluations.
